Form 4: Constellium SVP Sells 1,500 Shares

Stephen Charles Walters, SVP GC & Secretary of Constellium SE, sold 1,500 ordinary shares at a weighted average price of $25.39.

Summary

• Stephen Charles Walters, SVP GC & Secretary of Constellium SE (CSTM), reported a transaction involving the sale of ordinary shares.
• The transaction occurred on February 23, 2026, and involved the disposition of 1,500 ordinary shares.
• The shares were sold at a weighted average price of $25.39 per share.
• This sale was executed pursuant to a Rule 10b5-1(c) plan.
• Following this reported transaction, Stephen Charles Walters beneficially owns 0 ordinary shares.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a slightly negative signal, as a senior executive sold all their directly held ordinary shares, even if pre-planned, which could be interpreted as a lack of conviction in the stock's future performance.

Negatives

• A senior executive, Stephen Charles Walters, sold all 1,500 of his directly beneficially owned ordinary shares, reducing his direct ownership to zero.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider sales, even when executed under a pre-planned Rule 10b5-1 plan, are closely monitored by investors as they can sometimes be interpreted as a signal regarding management's perception of future company performance or valuation. This transaction involves an executive at an aluminum products company.

Comparison to Industry Standards

• NA This filing reports an insider transaction, not company performance metrics that can be directly compared to industry standards or specific competitors' results.

Stakeholder Impact

• Shareholders: May interpret the insider sale as a negative signal, potentially impacting investor confidence due to a senior executive divesting all direct holdings.

Key Dates

Recommendation

The sale by a senior executive, even under a Rule 10b5-1 plan, could be perceived negatively by the market, suggesting a lack of further upside from the insider's perspective. However, without additional negative company-specific news, it does not warrant a 'sell' recommendation, but rather a 'hold' as investors assess the implications.

Keywords

Constellium SE, CSTM, Insider Trading, Form 4, Share Sale, Executive Transaction, Stephen Walters, 10b5-1 Plan